OA3-3 Anti-PD-1 disrupts HIV latency in non-proliferating but not in proliferating T cells

• R.M. Van der Sluis,
• N.A. Kumar,
• V.A. Evans,
• A.I. Dantanarayana,
• R.P. Sékaly,
• R. Fromentin,
• N. Chomont,
• P.U. Cameron,
• S.R. Lewin

Affiliations

R.M. Van der Sluis

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia

N.A. Kumar

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia

V.A. Evans

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia

A.I. Dantanarayana

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia

R.P. Sékaly

Case Western University, Cleveland, USA

R. Fromentin

Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, Canada

N. Chomont

Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, Canada; Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, Canada

P.U. Cameron

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia

S.R. Lewin

Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Australia; Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia